Eltrombopag Olamine
Brand name: Promacta
Rank #121 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$142.8M
Total Cost
10,876
Total Claims
$142.8M
Total Cost
606
Prescribers
$13K
Cost per Claim
50
Beneficiaries
11,101
30-Day Fills
$236K
Avg Cost/Provider
18
Avg Claims/Provider
Share of Medicare Part D Spending
0.05%
of total Medicare Part D spending
$142.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $142.8M total
🔎 Data Overview
At $13,128 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $235,604 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $2,855,516 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Eltrombopag Olamine
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Richards Afonja | Hematology-Oncology | Clifton, NJ | 232 | $2.6M |
| 2 | Wahid Hanna | Hematology-Oncology | Knoxville, TN | 69 | $1.7M |
| 3 | Yogenthiran Saunthararajah | Hematology | Cleveland, OH | 40 | $1.5M |
| 4 | Alexis Cruz-Chacon | Hematology-Oncology | San Juan, PR | 34 | $1.1M |
| 5 | Syed Ahmed | Internal Medicine | El Centro, CA | 41 | $991K |
| 6 | Akash Mukherjee | Medical Oncology | Cincinnati, OH | 31 | $953K |
| 7 | John Hughes | Hematology-Oncology | Saginaw, MI | 66 | $896K |
| 8 | Robert Byram | Nurse Practitioner | New Orleans, LA | 27 | $808K |
| 9 | Chun Ng | Hematology-Oncology | Stockton, CA | 39 | $757K |
| 10 | James Tsai | Hematology-Oncology | Hemet, CA | 29 | $726K |
| 11 | Marc Hoffmann | Hematology-Oncology | Overland Park, KS | 19 | $698K |
| 12 | Sanjay Mohan | Hematology-Oncology | Nashville, TN | 31 | $660K |
| 13 | Yu Cheng | Hematology-Oncology | Orange, CA | 74 | $653K |
| 14 | Morey Blinder | Hematology | Saint Louis, MO | 38 | $640K |
| 15 | Liza Paulo Malave | Hematology-Oncology | Aguadilla, PR | 75 | $638K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 118 | Lisinopril (Lisinopril) | $145.8M | 15,744,768 |
| 119 | Ofatumumab (Kesimpta Pen) | $144.6M | 14,774 |
| 120 | Emtricitab/Rilpiviri/Tenof Ala (Odefsey) | $144.1M | 37,441 |
| 121 | Eltrombopag Olamine (Promacta) | $142.8M | 10,876 |
| 122 | Alpha-1-Proteinase Inhibitor (Prolastin C) | $137.9M | 12,352 |
| 123 | Dasatinib (Sprycel) | $136.8M | 10,389 |
| 124 | Oxycodone Hcl/Acetaminophen (Oxycodone-Acetaminophen) | $136.4M | 3,487,099 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology